CS
MRNS
Credit Suisse’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-20
| Closed | – | – | 4373 |
|
|
2022
Q2 | $0 | Buy |
+20
| New | – | ﹤0.01% | 4419 |
|
|
2022
Q1 | – | Sell |
-655
| Closed | -$7K | – | 3636 |
|
|
2021
Q4 | $7K | Buy |
+655
| New | +$7K | ﹤0.01% | 3606 |
|
|
2019
Q4 | – | Sell |
-11,931
| Closed | -$18K | – | 3599 |
|
|
2019
Q3 | $18K | Buy |
11,931
+90
| +0.8% | +$136 | ﹤0.01% | 3413 |
|
|
2019
Q2 | $49K | Buy |
+11,841
| New | +$49K | ﹤0.01% | 3354 |
|
|
2018
Q4 | – | Sell |
-1,033,326
| Closed | -$10.3M | – | 3423 |
|
|
2018
Q3 | $10.3M | Buy |
1,033,326
+899,780
| +674% | +$9M | 0.01% | 1012 |
|
|
2018
Q2 | $944K | Buy |
+133,546
| New | +$944K | ﹤0.01% | 2615 |
|
|
2016
Q1 | – | Sell |
-36,695
| Closed | -$280K | – | 3967 |
|
|
2015
Q4 | $280K | Sell |
36,695
-62,320
| -63% | -$476K | ﹤0.01% | 3493 |
|
|
2015
Q3 | $826K | Buy |
99,015
+77,267
| +355% | +$645K | ﹤0.01% | 2798 |
|
|
2015
Q2 | $252K | Buy |
+21,748
| New | +$252K | ﹤0.01% | 3816 |
|